- $1.59bn
- $1.45bn
- $4.89bn
- 52
- 50
- 66
- 56
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,386 | 3,721 | 6,421 | 6,018 | 4,885 |
Cost of Revenue | |||||
Gross Profit | 450 | 664 | 1,111 | 1,082 | 878 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,788 | 3,994 | 6,914 | 6,607 | 5,200 |
Operating Profit | -402 | -273 | -493 | -589 | -315 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -389 | -272 | -495 | -590 | -317 |
Provision for Income Taxes | |||||
Net Income After Taxes | -388 | -270 | -493 | -589 | -317 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -388 | -270 | -494 | -602 | -321 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -388 | -270 | -494 | -602 | -321 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1 | -0.659 | -1.42 | -1.31 | -0.644 |
Dividends per Share |